Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from U87MG cells expressing EGFRvIII


ABSTRACT: EGFRvIII is the most common deletion mutant of EGFR in human cancer and its levels are highly correlated with poor prognosis in GBM. The deletion of exons 2-7 removes most of the extracellular ligand binding domain, so it is unable to bind EGF or other EGFR-binding ligands. Nevertheless, the mutant receptor is constitutively phosphorylated, and is capable of activating downstream signaling pathways at a low level. To comprehensively identify the downstream signaling consequences of the EGFRvIII, we incorporated phosphoproteomic, transcription profiling and DNase-Seq data from U87MG glioblastoma cells expressing titrated levels of this mutant receptor. Total RNA were extracted from U87MG cells engineered to expressed different levels of EGFRvIII: medium (U87M; 1.5 million copies of EGFRvIII receptor per cell), high (U87H; 2 million copies per cell), super-high (U87SH; 2.5 million copies per cell), and kinase-dead EGFRvIII (U87DK; 2 million copies of kinase dead EGFRvIII per cell). RNA was hybridized to Affymetrix microarrays.

ORGANISM(S): Homo sapiens

SUBMITTER: Shao-shan Huang 

PROVIDER: E-GEOD-36901 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2013-01-01 | E-GEOD-36900 | biostudies-arrayexpress
2013-01-01 | GSE36901 | GEO
2013-12-20 | GSE53504 | GEO
2013-12-20 | E-GEOD-53504 | biostudies-arrayexpress
2015-09-14 | E-GEOD-72468 | biostudies-arrayexpress
2016-08-01 | E-GEOD-76959 | biostudies-arrayexpress
2016-08-01 | GSE76959 | GEO
| PRJNA483397 | ENA
2019-01-01 | GSE108658 | GEO
| PRJNA157209 | ENA